Home › Funds › Eagle Health Investments LP › BMRN

Eagle Health Investments LP position in BMRN

BIOMARIN PHARMACEUTICAL INC · Health Care

Eagle Health Investments LP reported holding 624,676 shares of BMRN (BIOMARIN PHARMACEUTICAL INC) in its Q2 2026 13F filing — a position valued at US$35.7M, representing 5.92% of its reported portfolio and ranking #5 among its reported holdings. Eagle Health Investments LP has disclosed BMRN holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)624.68K sh
Reported value held$35.74M
Portfolio Weight5.92%
First reportedQ2 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Eagle Health Investments LP's BMRN position evolved

Eagle Health Investments LP first disclosed a stake in BMRN in Q2 2024 at 231,800 shares (US$19.1M). The position peaked in Q2 2026 at 624,676 shares, worth US$35.7M. Across 9 filings, Eagle Health Investments LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 624,676 shares valued at US$35.7M — an increase of 118,867 shares quarter over quarter.. Notable position changes include a 81% increase in Q3 2024 (shares fell 6% over the following quarter), a 38% increase in Q1 2026 (shares rose 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 231.80K $19.08M New
Q3 2024 419.21K $29.47M Add
Q4 2024 419.21K $27.55M Hold
Q1 2025 382.61K $27.05M Reduce
Q2 2025 366.81K $20.16M Reduce
Q3 2025 366.81K $19.87M Hold
Q4 2025 366.81K $21.80M Hold
Q1 2026 505.81K $28.57M Add
Q2 2026 624.68K $35.74M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BMRN and 13F data

BMRN (BIOMARIN PHARMACEUTICAL INC) is a Health Care company. 27 other funds we track also report a position in BMRN — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$812.0M), Viking Global Investors (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BMRN

All BMRN fund holders →

FAQ

How long has Eagle Health Investments LP held BMRN?

Eagle Health Investments LP has disclosed BMRN holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is Eagle Health Investments LP's current position in BMRN?

As of Q2 2026, Eagle Health Investments LP holds 624.68K shares of BMRN (BIOMARIN PHARMACEUTICAL INC), valued at $35.74M, representing 5.92% of its reported portfolio and ranking #5.

Has Eagle Health Investments LP been buying or selling BMRN?

In the latest 13F filing (Q2 2026), Eagle Health Investments LP increased its position in BMRN. The position peaked in Q2 2026 at 624.68K shares.

Which other funds hold BMRN?

Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.